resectable pancreatic cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadceliac disease

I am/have/hadmetastasis

I am/have/hadpancreatic adenocarcinoma

I am/have/hadplatelet count

I am/have/hadneutrophil count

I am/have/hadcancer

I am/have/hadpancreatic cancer

I am/have/hadendoscopic ultrasound

I am/have/hadresectable pancreatic cancer

I am/have/hadadenocarcinoma

added new label for I am/have/had

more

I am looking for

I am looking forcisplatin

I am looking foroxaliplatin

I am looking foririnotecan

I am looking forgemcitabine

I am looking forleucovorin

I am looking forpaclitaxel

I am looking forfluorouracil

I am looking forcapecitabine

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Giving NBTXR3 followed by radiation therapy may work better to treat locally advanced or borderline-resectable pancreatic cancer compared to radiation therapy alone.

celiac disease

cisplatin

irinotecan

gemcitabine

pancreatic cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.